May 6th 2024
For neuroradiologists, the Signa Magnus 3T MRI system may offer enhanced visualization of the brain microstructure, microvasculature, and function.
Philips Gets FDA Nod for MRI Head and Neck Radiotherapy Application
October 20th 2022For physicians performing radiotherapy treatment of soft tissue tumors in the head and neck, the MRCAT Head and Neck offers an artificial intelligence (AI) application that allows the use of magnetic resonance imaging (MRI) as the primary or sole imaging for procedure planning.
Recognizing the Role of Enterprise Imaging in Handling and Protecting Sensitive Patient Information
October 19th 2022While facilitating interdisciplinary colloaboration is a central objective with enterprise imaging platforms, this author says implementation of these platforms must ensure optimal patient privacy in sensitive cases involving abuse, assault and domestic violence.
Could Brain MRI Screening be Beneficial for Patients with Inflammatory Breast Cancer?
October 11th 2022While current consensus guidelines do not recommend the use of brain MRI screening in patients with breast cancer, a new study shows significantly elevated risks for the development of central nervous system metastasis in patients with inflammatory breast cancer.
Adjunctive AI Software for Brain MRI Gets FDA Clearance for Assessing High-Grade Gliomas
October 10th 2022Incorporating artificial intelligence (AI)-based technology, Neosoma HGG reportedly demonstrated a 95.5 percent accuracy rate in measuring brain tumor volume on brain magnetic resonance imaging (MRI) scans at various points during the treatment of patients with high-grade gliomas.
MRI Deep Learning Software from GE Healthcare Gets Expanded FDA Clearance
September 29th 2022AIR Recon DL, a deep learning-based image reconstruction software, will now be available with 3D sequences as well as PROPELLER motion-insensitive sequences on magnetic resonance imaging (MRI) scanners from GE Healthcare.
FDA Approves New MRI Contrast Agent Gadopiclenol
September 22nd 2022Requiring only half of the gadolinium dose of current non-specific gadolinium-based contrast agents (GBCAs), gadopiclenol can be utilized with magnetic resonance imaging (MRI) to help detect lesions with abnormal vascularity in the central nervous system and other areas of the body.
Managing Incidentalomas in Radiology: Embracing Challenges as Opportunities
September 12th 2022Greater imaging utilization has increased the prevalence of incidental findings or incidentalomas, but unclear clinical context and guidelines complicate management. Accordingly, these authors offer a thorough review of the literature and discuss new opportunities for improving interdisciplinary management strategies.
Key MRI Patterns for Diagnosing Inflammatory Brain Stem Lesions
July 16th 2022In an award-winning presentation at the European Congress of Radiology (ECR), researchers from the Hospital Universitario Basurto in Spain reviewed key neuroimaging findings on magnetic resonance imaging (MRI) for a variety of inflammatory lesions of the brain stem.
New Study Says Five Out of Eight Face Masks Are 'MRI Unsafe'
July 11th 2022In their testing of eight commercially available filtering face piece (FFP3) respirators commonly utilized during the COVID-19 pandemic, researchers deemed that five of the face masks that contained ferromagnetic materials were unsafe to use in and around magnetic resonance imaging (MRI) devices.